Cough Syrup Market Share: Overview: Current Trends And Future Aspect Analysis to 2027 | Acella Pharmaceuticals LLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson

According to the latest report by IMARC Group, titled "𝐂𝐨𝐮𝐠𝐡 𝐒𝐲𝐫𝐮𝐩 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟐-𝟐𝟎𝟐𝟕," offers a comprehensive analysis of the industry, which comprises insights on the global smart parking market share. The report also includes competitor and regional analysis, and contemporary advancements in the global market. 

𝐂𝐨𝐮𝐠𝐡 𝐒𝐲𝐫𝐮𝐩 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞:

The global cough syrup market size reached US$ 5.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7 Billion by 2027, exhibiting a growth rate (CAGR) of 4.4% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

𝐂𝐨𝐮𝐠𝐡 𝐒𝐲𝐫𝐮𝐩 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐡𝐚𝐫𝐞

Cough syrup refers to a combination drug that is used to provide temporary relief from cough, common cold, hay fever, and other respiratory allergies. It is manufactured using non-opioid cough suppressants, expectorants, and antihistamine compounds to block the symptoms. The suppressants help in alleviating the symptoms of dry cough by minimizing the activity of the cough reflex and reducing the urge to cough. The expectorants aid in treating cough with mucus by loosening it, thereby making it easier to expel from the body. The antihistamines are utilized to relieve cough caused by minor throat or airway irritation. Cough syrups are generally prescribed by doctors or are available over-the-counter (OTC) in pharmacy stores in a wide variety of flavors, including cherry, orange, honey, and bubblegum.

Receive A Full PDF Sample Copy Of Report:( Including Full TOC, List of Tables & Figures, Chart): https://www.imarcgroup.com/cough-syrup-market/requestsample

Current Trends & Future Predictions 

The elevating prevalence of upper respiratory tract infection (URTI) and other respiratory disorders across countries is among the key factors stimulating the cough syrup market. Furthermore, the inflating health consciousness among the masses and convenient product availability in pharmacies and general stores are also propelling the global market. Moreover, various innovations, including the development of cough syrups with minimal side effects, are acting as other significant growth-inducing factors. Besides this, manufacturers are developing variants fortified with natural herbs and ingredients with immunity-boosting effects, which is further fueling the market growth. Apart from this, the growing expenditure capacities of the consumers and the expanding pharmaceutical industry are expected to positively influence the cough syrup market in the coming years.

Key Players in Cough Syrup Market 

• Acella Pharmaceuticals LLC
• Bayer AG (OTCMKTS: BAYRY)
• GlaxoSmithKline PLC
• Johnson & Johnson (NYSE: JNJ)
• Pfizer Inc.
• Prestige Consumer Healthcare Inc.
• Reckitt Benckiser Group PLC
• Sanofi
• Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA)
• The Procter & Gamble Company (NYSE: PG)

Market Segmentation of the Cough Syrup Market 

The report has segmented the global cough syrup market on the basis of product type, age group, distribution channel and region.

Based on Product Type:

• Expectorants
• Cough Suppressants/Antitussives
• Combination Medications

Based on Age Group:

• Pediatric
• Adult

Based on Distribution Channel:

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Geographical Analysis:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Explore Full Report Description At: https://www.imarcgroup.com/cough-syrup-market

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.